Mechanistically, it might induce glioma cell apoptosis through ERK1/2-mediated mitochondrial dysfunction and control glioma cell growth by modulating wild-type p53 activation or mutant p53 inhibition [154]. The gene discussed is TP53; the disease is central nervous system cancer.